Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre-Reference-Cited by-同舟云学术

Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre

Published:2019-05 Issue:3 Volume:25 Page:149-153
ISSN:2531-0437
Container-title:Pulmonology
language:en
Short-container-title:Pulmonology

Author:

Bargagli E.,Piccioli C.,Rosi E.,Torricelli E.,Turi L.,Piccioli E.,Pistolesi M.,Ferrari K.,Voltolini L.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference20 articles.

1. Diffuse idiopathic interstitial pneumonias, International multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society, principal clinico-pathological entities, and diagnosis;Cottin;Rev Mal Respir,2004

2. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

3. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature;Nalysnyk;Eur Respir Rev,2012

4. Long-term treatment of patients with idiopathic pulmonary fibrosis with Nintedanib: results from the TOMORROW trial and its open-label extension;Richeldi;Thorax,2017

5. A phase 3 trial of Pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells;British Journal of Pharmacology;2024-08-25

2. Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-07-04

3. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18

4. Preparation and evaluation of inhalable S-allylmercapto-N-acetylcysteine and nintedanib co-loaded liposomes for pulmonary fibrosis;European Journal of Pharmaceutical Sciences;2024-06

5. Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows;Pharmaceuticals;2024-05-30